Mini-symposia

Last day of the conference (Thursday) will be devoted to two mini-symposia, one on Biomedical informatics (organisers Jana Zvárová and Ulrich Mansmann) and the other on Statistics in Vaccines Research (organisers Marc Fourneau, Jingyee Kou and  Allen Izu).

The mini-symposium on Biomedical Informatics will help elucidate close relationship between Biomedical Informatics and Biostatistics on issues from molecular medicine.

The mini-symposium on Statistics in Vaccines Research has already taken place in Alexandroupolis in Greece (ISCB 2007) and also in Copenhagen, Denmark (ISCB 2008). In Prague the organisers are hoping for another highly succesful meeting of biostatisticians and medical researchers interested in statistical methodology applied in the context of vaccines research.

Mini-symposium on Biomedical Informatics
Organisers: 
Ulrich Mansmann (Ludwig-Maximilians-Universität, Munich, Germany)
Jana Zvárová (Institute of Computer Science AS CR, Prague, Czech Republic)
Speakers: 
Wolfgang Huber (European Bioinformatics Institute, Cambridge, U.K.): Recent developments in statistical software for analysis of complex genomic data 
Alvis Brazma (European Bioinformatics Institute, Cambridge, U.K.): Development of data integration for cellular data, development of software and standards to handle related problems
Igor Vajda (Institute of Information Theory and Automation AS CR, Prague, Czech Republic): Information theory models for clinical decision support
Pirkko Nykänen (University of Tampere, Finland): Data and information in electronic health records-current situation and challenges for the future
Jan H. van Bemmel (Erasmus University of Rotterdam, The Netherlands): R&D for knowledge and decisions in healthcare

Mini-symposium on Statistics in Vaccines Research
Organisers: 
Marc Fourneau (GlaxoSmithKline Biologicals, Rixensarl, Belgium)
Jingyee Kou (Food and Drug Administration, Division of Biostatistics, Rockville, MD, U.S.A.)
Allen Izu (Novartis Vaccines, Cambridge, MA, U.S.A.)
Speakers: 
Robert C. Kohberger (Statistical Consultant, Greenwich, CT, U.SA.): Practical Issues in Vaccine Trial Interim Analysis
Jonathan Hartzel, Ivan SF Chan (Merck Research Laboratories, Clinical Biostatistics, North Wales, U.S.A.): Interim Analysis Strategies for Adaptation in Seamless Phase II/III Vaccine Trials
Bernhard Klingenberg (Williams College, Williamstown, MA, U.S.A.): Simultaneous Upper Confidence Bounds for the Relative Risk in Multiple Comparisons to Control
Henry S. Hsu (Division of Biostatistics, Office of Biostatistics & Epidemiology, US FDA/CBER, Rockville, MD, U.S.A.): Multiple Endpoints in Vaccine Trials
Allen Izu (Novartis Vaccines, Cambridge, MA. U.S.A),  Marc Fourneau (GlaxoSmithKline Biologicals, Rixensarl, Belgium): Challenges for Flu Pandemic Vaccines